Yahoo! has expanded its Health offering, deepening content and offering three new search apps it says will enable advertisers to better reach target audiences, including through contextual advertising.
The number of providers placed on probation by the Accreditation Council for Continuing Medical Education more than doubled this year, from 15 to 35, and 14 (40%) appear to be small physician associations.
Of about 55,000 PCPs attending Pri-Med conferences, 70% (around 39,000) attend non-CME industry-led speaker programs while at its events, showed a survey by the producer of medical meetings aimed at primary care doctors.
Total commercial support of accredited CME fell 17% to $856 million in 2009, according to ACCME’s annual report–marking its second straight year of double-digit declines on a percentage basis.
Watson beefs up women’s health biz, adds 19 sales reps
Generics and specialty pharma Watson Pharmaceuticals acquired a progesterone gel, marketed as Crinone and Prochieve, and added roughly 19 reps to its women’s health sales force.
PhRMA said the reasoning behind a sharp cap on samples mandated by its European counterpart doesn’t apply in the US.
Eisai launches online resource
July 15, 2010
8:40 pm
Eisai unveiled an online resource for nurses treating cancer patients.
Sage upgrades online journal platform
July 15, 2010
8:38 pm
Sage, an international publisher of medical journals, books and electronic media, is shifting all of its 560-plus titles onto a new platform hosted by Stanford University Libraries’ HighWire Press.
How can mobile improve access?
July 15, 2010
2:14 pm
Millions of patients across the country are set to enter the healthcare system, each with different insurance plans and tolerance for drug co-pays. How are you using mobile technology and social media to improve access?
Headliner: Kowa Pharmaceuticals America’s Ben Stakely
At first glance, Nagoya, Japan-based Kowa, which last month launched a statin, Livalo, in the US, looks to be running a somewhat counterintuitive play, expanding into a market in decline and starting with a category in decline–at least for branded pharmas.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix